|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-6-11
|
|
pubmed:abstractText |
Stage IIIA,B breast cancer is commonly treated with neoadjuvant chemotherapy because of high objective response rates and improved operability. Criteria for subsequent selection of local therapy--mastectomy, radiotherapy, or both--are not well defined. We adopted a policy of selective local therapy based on rebiopsy of the breast and clinical axillary lymph node status at the time of best response to chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
pubmed-author:ChaudhryUU,
pubmed-author:ChouEE,
pubmed-author:CostaL SLS,
pubmed-author:DanforthD NDNJr,
pubmed-author:JacobsonJJ,
pubmed-author:LippmanMM,
pubmed-author:McAteeNN,
pubmed-author:NooneMM,
pubmed-author:O'ShaughnessyJJ,
pubmed-author:OkunieffPP,
pubmed-author:RisebergDD,
pubmed-author:SteinbergS MSM,
pubmed-author:ZujewskiJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
150-8
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9527268-Adult,
pubmed-meshheading:9527268-Aged,
pubmed-meshheading:9527268-Axilla,
pubmed-meshheading:9527268-Biopsy,
pubmed-meshheading:9527268-Breast Neoplasms,
pubmed-meshheading:9527268-Carcinoma, Ductal, Breast,
pubmed-meshheading:9527268-Carcinoma, Lobular,
pubmed-meshheading:9527268-Chemotherapy, Adjuvant,
pubmed-meshheading:9527268-Clavicle,
pubmed-meshheading:9527268-Disease-Free Survival,
pubmed-meshheading:9527268-Female,
pubmed-meshheading:9527268-Follow-Up Studies,
pubmed-meshheading:9527268-Humans,
pubmed-meshheading:9527268-Incidence,
pubmed-meshheading:9527268-Lymph Node Excision,
pubmed-meshheading:9527268-Lymph Nodes,
pubmed-meshheading:9527268-Lymphatic Metastasis,
pubmed-meshheading:9527268-Mastectomy,
pubmed-meshheading:9527268-Mastectomy, Segmental,
pubmed-meshheading:9527268-Middle Aged,
pubmed-meshheading:9527268-Neck,
pubmed-meshheading:9527268-Neoplasm Recurrence, Local,
pubmed-meshheading:9527268-Neoplasm Staging,
pubmed-meshheading:9527268-Probability,
pubmed-meshheading:9527268-Radiotherapy, Adjuvant,
pubmed-meshheading:9527268-Remission Induction,
pubmed-meshheading:9527268-Survival Rate,
pubmed-meshheading:9527268-Thoracic Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
|
|
pubmed:affiliation |
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
|
|
pubmed:publicationType |
Journal Article
|
